These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy. Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry. Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542 [TBL] [Abstract][Full Text] [Related]
6. Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach. Rosa RCA; Santis JO; Teixeira LA; Molfetta GA; Dos Santos JTT; Ribeiro VDS; Chahud F; Ribeiro-Silva A; Brunaldi MO; Silva WA; Ferraz VEF Gynecol Oncol; 2020 Oct; 159(1):229-238. PubMed ID: 32694065 [TBL] [Abstract][Full Text] [Related]
7. Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing. Alqahtani M; Edwards C; Buzzacott N; Carpenter K; Alsaleh K; Alsheikh A; Abozeed W; Mashhour M; Almousa A; Housawi Y; Al Hawwaj S; Iacopetta B Fam Cancer; 2018 Apr; 17(2):197-203. PubMed ID: 28643016 [TBL] [Abstract][Full Text] [Related]
8. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome. Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759 [TBL] [Abstract][Full Text] [Related]
9. Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients. Kato A; Sato N; Sugawara T; Takahashi K; Kito M; Makino K; Sato T; Shimizu D; Shirasawa H; Miura H; Sato W; Kumazawa Y; Sato A; Kumagai J; Terada Y Am J Surg Pathol; 2016 Jun; 40(6):770-6. PubMed ID: 26848797 [TBL] [Abstract][Full Text] [Related]
10. A practical screening strategy for Lynch syndrome and Lynch syndrome mimics in colorectal cancer. Yao ZG; Lv BB; Jing HY; Su WJ; Li JM; Fan H; Zhao MQ; Qin YJ; Sun XC J Cancer Res Ther; 2021 Jul; 17(3):790-796. PubMed ID: 34269315 [TBL] [Abstract][Full Text] [Related]
11. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer. Carethers JM; Stoffel EM World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352 [TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome. Pearlman R; Haraldsdottir S; de la Chapelle A; Jonasson JG; Liyanarachchi S; Frankel WL; Rafnar T; Stefansson K; Pritchard CC; Hampel H J Med Genet; 2019 Jul; 56(7):462-470. PubMed ID: 30877237 [TBL] [Abstract][Full Text] [Related]
13. Importance of PCR-based Tumor Testing in the Evaluation of Lynch Syndrome-associated Endometrial Cancer. Bruegl AS; Kernberg A; Broaddus RR Adv Anat Pathol; 2017 Nov; 24(6):372-378. PubMed ID: 28820751 [TBL] [Abstract][Full Text] [Related]
14. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer. Hampel H; Pearlman R; Beightol M; Zhao W; Jones D; Frankel WL; Goodfellow PJ; Yilmaz A; Miller K; Bacher J; Jacobson A; Paskett E; Shields PG; Goldberg RM; de la Chapelle A; Shirts BH; Pritchard CC; JAMA Oncol; 2018 Jun; 4(6):806-813. PubMed ID: 29596542 [TBL] [Abstract][Full Text] [Related]
15. Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome. Tamura K; Kaneda M; Futagawa M; Takeshita M; Kim S; Nakama M; Kawashita N; Tatsumi-Miyajima J Int J Clin Oncol; 2019 Sep; 24(9):999-1011. PubMed ID: 31273487 [TBL] [Abstract][Full Text] [Related]
16. Identification of Lynch Syndrome. Maratt JK; Stoffel E Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):45-58. PubMed ID: 34798986 [TBL] [Abstract][Full Text] [Related]
17. Universal screening for Lynch syndrome in operated colorectal cancer by immunohistochemistry: a cohort of patients in Liaoning province, China. Zhao G; Xiang G; Hu X; Qiao Y; Ma S; Tian Y; Gao X; Liu F; Li X; Shi G Eur J Cancer Prev; 2023 Jul; 32(4):337-347. PubMed ID: 36942852 [TBL] [Abstract][Full Text] [Related]
18. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community. Schofield L; Goldblatt J; Iacopetta B Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021 [TBL] [Abstract][Full Text] [Related]
19. Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas. Ju JY; Mills AM; Mahadevan MS; Fan J; Culp SH; Thomas MH; Cathro HP Am J Surg Pathol; 2018 Nov; 42(11):1549-1555. PubMed ID: 30148743 [TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Bellizzi AM; Frankel WL Adv Anat Pathol; 2009 Nov; 16(6):405-17. PubMed ID: 19851131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]